| Primary information |
|---|
| ID | 1520 |
| Peptide Name | SEQ ID13 |
| Sequence | r-nL-nL-nL-r-nL-nL-nLGy |
| Length | 10 |
| Chirality | Mix |
| N-terminal Modification | Acetylation |
| C-terminal Modification | Amidation |
| Chemical Modification | nL = norleucine |
| Linear/ Cyclic | Linear |
| Nature | Synthetic |
| Source of Origin | NA |
| Target | NA |
| Mechanism of Action | Inhibited T-cell proliferation, various inflammatory cytokines production. |
| In vitro/In vivo | In vivo |
| Cell Line | None |
| Inhibition Concentartion | 2.5-10micromolar against binding to peptides to HSC95 |
| In vivo Model | C57BL6/J, Balb/c and CBA/J mice |
| Assay | Enzyme-linked immunosorbent assay (ELISA) |
| Lethal Dose | NA |
| Combination Therapy | LPS |
| Pubmed ID | US 7267822 B2 |
| Year of Publication | 2007 |
| 3-D Structure | NA |
